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Smoking tobacco is one of the leading causes of death around the world, and it is also a 
critical risk factor for many chronic diseases, including lung cancer and heart disease. Although 
smoking rates have declined in many countries, tobacco use continues to be a problem in other 
regions, such as the Pacific Islands, where 30–50% of the population are smokers. Researchers 
have reported that smoking behaviors are influenced by both environmental and genetic factors, 
but the specific loci involved are mostly unknown. In addition, the majority of genetic studies have 
been conducted in Caucasian populations, so the results may not be applicable to other ethnic 
groups. I investigated whether 20 genetic variants reported to influence smoking behaviors had a 
similar effect in Samoans, using genotype and demographic data available for 3,476 Samoan 
participants from the Soifua Manuia (Good Health) study. I also compared the allele frequencies 
(AFs) of these 20 loci in Samoans to those in other ethnic groups using principal component 
analysis. As expected, the Samoan population clustered most closely with East Asian populations, 
yet they had unique AFs for many loci. Regarding smoking phenotypes, males were more likely 
to be current smokers (CS) (p < 2.2×10-16), and they smoked more cigarettes per day (CPD) than 
females (p = 2.0×10-12). The association analyses revealed that the G allele of locus rs848353 was 
associated with increased odds of being a current smoker (OR = 2.635 [2.433–35.63]; p = 0.001), 
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whereas the G allele of rs1329650 corresponded to a significant increase in CPD ( = 0.146  
0.044; p = 0.001); both variants are in noncoding regions of the genome. Additional genetic studies 
in Polynesians are needed to confirm these findings and help us understand the function of these 
noncoding regions in the etiology of addictive disorders. This knowledge may help development 
of targeted interventions for smoking cessation, eventually leading to a reduction in chronic 
disease morbidity and mortality and overall improving public health in Samoa. 
 vi 
Table of Contents 
Preface ............................................................................................................................................ x 
1.0 Introduction ............................................................................................................................. 1 
1.1 Smoking: A Public Health Issue .................................................................................... 1 
1.2 Prevalence of Smoking in Samoa .................................................................................. 2 
1.2.1 Social Factors & Trends in Smoking Initiation................................................ 3 
1.3 Genetic Factors ............................................................................................................... 4 
1.3.1 Evolutionary History of Samoans ...................................................................... 4 
1.3.2 Genetics of Nicotine Dependence ....................................................................... 5 
1.4 Specific Aims ................................................................................................................... 8 
2.0 Methods .................................................................................................................................... 9 
2.1 Samples & Genotyping................................................................................................... 9 
2.2 Smoking-Related Phenotypes ...................................................................................... 10 
2.2.1 Current Smoking Status ................................................................................... 10 
2.2.2 Cigarettes Per Day ............................................................................................ 10 
2.3 Candidate Genes & SNVs ............................................................................................ 11 
2.4 Statistical Testing.......................................................................................................... 13 
2.4.1 Population Characteristics ............................................................................... 13 
2.4.2 Principal Component Analysis ........................................................................ 13 
2.4.3 Association Testing ........................................................................................... 13 
3.0 Results .................................................................................................................................... 15 
3.1 Demographics ............................................................................................................... 15 
 vii 
3.2 Smoking Trends & Distribution.................................................................................. 16 
3.3 Allele Frequencies ......................................................................................................... 17 
3.4 Association Analyses .................................................................................................... 19 
4.0 Discussion............................................................................................................................... 22 
4.1 Limitations .................................................................................................................... 26 
4.2 Future Research............................................................................................................ 27 
Appendix ...................................................................................................................................... 29 
Bibliography ................................................................................................................................ 32 
 viii 
List of Tables 
Table 1 Nicotine content in tobacco products .......................................................................... 11 
Table 2 Candidate SNVs associated with smoking behaviors ................................................ 12 
Table 3 Demographic variables ................................................................................................. 15 
Table 4 Allele frequencies by population .................................................................................. 18 
Table 5 SNVs associated with smoking phenotypes (additive model) .................................... 20 
Table 6 SNVs associated with smoking phenotypes (by genotype) ........................................ 20 
Appendix Table 1 Populations in the 1000 Genomes Project ................................................. 29 
Appendix Table 2 Results of association testing (additive model) ......................................... 29 
Appendix Table 3 Results of association testing (by genotype) .............................................. 30 
 
 ix 
List of Figures 
Figure 1 Age distribution of study participants ....................................................................... 15 
Figure 2 Age of smoking initiation ............................................................................................ 16 
Figure 3 Cigarettes smoked per day.......................................................................................... 17 
Figure 4 PCA plot of population allele frequencies ................................................................. 19 
Figure 5 Proportion of smokers by genotype for rs848353 ..................................................... 21 




We would like to thank the Samoan participants and local village authorities and research 
assistants over the years. We acknowledge the support of our research collaboration with the 
Samoa Ministry of Health; the Samoa Bureau of Statistics; and the Samoa Ministry of Women, 
Community and Social Development. The Samoan Obesity, Lifestyle, and Genetics Adaptations 
(OLaGA) Study Group investigators are Ranjan Deka, Jenna Carlson, Kima Fa‘asalele-Savusa, 
Nicola L. Hawley, Vaimoana Lupematisila, Stephen T. McGarvey, Ryan L. Minster, Leausa 
Toleafoa Take Naseri, Muagututi‘a Sefuiva Reupena, Melania Selu, John Tuitele, Asiata 
Satupa‘itea Viali and Daniel E. Weeks.
 1 
1.0 Introduction 
1.1 Smoking: A Public Health Issue 
Tobacco use has long been one of the world’s biggest health issues, and smoking is one of 
the leading causes of premature death. In 2017 alone, smoking accounted for more than 7 million 
deaths globally (Stanaway et al., 2018). In addition, tobacco use is the biggest external risk factor 
for many chronic diseases, including lung cancer, heart disease, and respiratory diseases, which 
are also among the leading causes of death around the world (Jha & Peto, 2014). Thanks to public 
health interventions, smoking rates have decreased in many countries, but tobacco use continues 
to be a problem in certain regions of the world. 
Rates of smoking often correlate with a country’s level of economic development. An 
article by Jha and Peto in the New England Journal of Medicine described the shifting trends in 
tobacco use around the world. They noted that high-income, developed countries had high smoking 
rates throughout the 20th century. However, there has since been a dramatic decline in the 
prevalence of smoking due to persistent public health efforts, and cigarette consumption per adult 
has been nearly halved in some countries (Jha & Peto, 2014). Unfortunately, smoking prevalence 
has shifted to low and middle-income countries (defined by World Bank gross national income 
standards), where smoking cessation is still uncommon. Bilano and colleagues modeled global 
trends in smoking prevalence from 2010 to 2025 in men and women; they reported that tobacco 
use among men will likely increase in low and middle-income countries in eastern Europe, the 
western Pacific, and Africa. Tobacco control may not be a top priority in these countries due to 
limited resources and the need to address other pressing health concerns (Bilano et al., 2015). 
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Future global health interventions (e.g., awareness, prevention efforts, etc.) should be focused on 
these low-to-middle income countries to help them bring down the rates of smoking in their 
populations. 
1.2 Prevalence of Smoking in Samoa 
In the Pacific Islands, a region of the world that is already experiencing a rise in non-
communicable diseases due to globalization and changing diets/behaviors, tobacco smoking adds 
to the burden by increasing the risk of developing these diseases. Southeast Asia and the Pacific 
region have some of the highest rates of smoking in the world, particularly among men, ranging 
from 30–50% of the population (Adia, Hawley, Naseri, Reupena, & McGarvey, 2019). This is 
substantially higher than the global smoking rate estimated by the World Health Organization: 
20.2% of individuals aged ≥ 15 are current smokers (Commar, Prasad, d’Espaignet, & Wolfenden, 
2018). 
Tobacco use has steadily declined in Samoa over the years, from nearly 64.1% of men and 
21.0% of women smoking tobacco in 1991, to 39.5% and 16.8%, respectively, in 2013 (Linhart et 
al., 2017). Linhart and colleagues analyzed population-based surveys of Samoans aged 25–64 and 
found that daily tobacco smoking also substantially dropped from 1978 (75.8% in men; 26.5% in 
women) to 2013 (36.3% in men; 14.9% in women). Despite the progressive decrease, the 
percentage of male smokers still remains fairly high. The prevalence of tobacco use among 
younger age groups is worrisome as well, with 32.2% of Samoan adolescents smoking cigarettes, 
which is higher than in other low and middle-income countries (Adia et al., 2019). These 
percentages illustrate the extent to which smoking is a significant public health concern in Samoa. 
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1.2.1  Social Factors & Trends in Smoking Initiation 
Tobacco use around the world is often associated with men of lower levels of education 
and socioeconomic status (Adia et al., 2019). These trends were also reflected in the Samoan 
population. A 2005 cross-sectional study of 1,834 Samoan adults found that current smokers were 
more likely to be male, younger (18–34 years), single, and have lower incomes (< $20,000/year) 
(Mishra, Osann, & Luce, 2005). The 2014 Demographic and Health Survey conducted by the 
Samoan government noted that among males aged 15–49, those in the highest wealth quintile and 
with more than secondary education generally had lower rates of tobacco use (Adia et al., 2019). 
Smoking is well entrenched in Samoan society and is seen as a way of socializing with 
friends and sometimes family. Based on results from focus groups conducted in Apia, Samoa’s 
capital city, Tanielu et al. found that most individuals had their first smoking experience in a social 
gathering with peers. This first experience commonly occurred in the late teens and early twenties. 
Many individuals stated that they started out of curiosity or picked up the habit along with drinking. 
Results from the focus groups also revealed some widely held misconceptions that smoking is 
beneficial in increasing energy, relieving indigestion, and accelerating the effects of alcohol. 
Female smokers viewed it as a relief from the stress and pressures of their daily lives (Tanielu, 
McCool, Umali, & Whittaker, 2018). 
Despite citing the perceived benefits of smoking, the majority of Samoans acknowledge 
that tobacco use is generally harmful to health. Moreover, 81% of participants in the focus groups 
expressed that they intended to quit smoking and two-thirds of the group had previously tried to 
quit. The primary reasons for giving up the habit were out of concern for family and tensions at 
home. The cost of cigarettes took a toll on finances, and smokers often found it difficult to 
prioritize the needs of the family over the desire to satisfy their addiction (Tanielu et al., 2018). 
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1.3 Genetic Factors 
1.3.1  Evolutionary History of Samoans 
The region of Oceania was first inhabited at least 50,000 years ago by the ancestors of 
Aboriginal Australians and Papuans. A second wave of migration occurred 5,000 years ago when 
the region was colonized by peoples from the islands of Southeast Asia who spoke Austronesian 
languages. Genetic analyses show that there was initially minimal admixture between the 
Austronesians and the Papuans. However, as expected, admixture increased over time, and 
modern-day speakers of Austronesian languages in the Pacific have 70–80% Austronesian and 20–
30% Papuan ancestry (Harris et al., 2020). 
The island of Samoa was founded around 2,800 years ago. Researchers hypothesize that 
early inhabitants initially lived in small, isolated groups that later formed into a system of complex 
chiefdoms. Unfortunately, the island’s sparse early archaeological record has made it difficult to 
decipher its population history (Harris et al., 2020). Population genetics may help answer some of 
these questions which is why it is crucial to include these groups in genetic studies; yet Oceanic 
populations, and Polynesian populations in particular, continue to be undersampled in research. 
The phenomenon of genetic drift due to founder effects, small/isolated populations, and population 
bottlenecks has led to unique variants and allele frequencies (AFs) in Samoans (Minster et al., 
2016). Comparing the frequencies of these variants with those in other populations can provide 
important insight into the genetics behind various phenotypic traits. 
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1.3.2  Genetics of Nicotine Dependence 
Nicotine is the primary addictive compound in tobacco products, and tobacco use is 
specifically motivated by nicotine dependence (ND). Understanding the factors that contribute to 
ND is necessary in order to decrease the prevalence of smoking. Addiction is not commonly 
regarded in a hereditary context, yet numerous studies have shown that there is a significant genetic 
component to many addictive behaviors, including ND. Multiple quantitative genetic studies 
conducted on monozygotic (identical), dizygotic (fraternal) twins, and adopted children from many 
ethnic groups reported that heritability of ND and the number of cigarettes smoked per day (CPD) 
was consistently between 50–60%, after accounting for variation due to environmental factors 
(Gorwood, Le Strat, & Ramoz, 2017; Mackillop, Obasi, Amlung, McGeary, & Knopik, 2010; 
Yoon et al., 2012). However, these studies do not provide insight into the specific genes associated 
with increased risk of addiction. 
To identify possible susceptibility genes, one approach is to assess variation in genes 
involved in the molecular pathways for nicotine metabolism. Genes associated with differences in 
nicotine pharmacokinetics, which is a person’s metabolic capacity, are most likely implicated in 
ND (Mackillop et al., 2010). Individuals that metabolize nicotine faster are more dependent on it 
and exhibit greater ND. On the other hand, people with slower nicotine metabolism tend to have 
lower CPD counts. They also respond better to nicotine patch therapy and thus have a higher 
probability of successful smoking cessation (Claw et al., 2020). 
Nicotine metabolism is largely determined by CYP2A6, the primary enzyme that catalyzes 
the conversion of approximately 75% of the nicotine that enters the body into cotinine. The enzyme 
is encoded by the highly polymorphic CYP2A6 gene; some genetic variants substantially reduce 
enzymatic metabolism of nicotine, while others increase nicotine metabolism. Individuals with a 
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loss-of-function mutation in just one allele have ~50% decrease in enzymatic activity and slower 
metabolism compared to wild-type. The CYP2B6 enzyme also metabolizes nicotine in the liver 
but does so less efficiently than CYP2A6. A recent study found that CYP2A6 and CYP2B6 interact 
and balance each other out if there is a deficiency in one of the enzymes (Mackillop et al., 2010). 
The receptors in this pathway also play an important role in mediating nicotine metabolism. 
Nicotine acts as an agonist for nicotinic acetylcholine receptors (nAChRs), a family of ligand-
gated ion channels that are expressed in the brain and various other tissues (Conlon & Bewick, 
2011). The CHRNA5-CHRNA3-CHRNB4 gene cluster on the long arm of chromosome 15q25 
encodes the α5, α3, and β4 subunits of the receptors, respectively, and genetic variants in this 
region have been associated with ND and other smoking-related traits. In particular, the 
nonsynonymous variant rs16969968 in CHRNA5 has consistently yielded the strongest association 
with ND, as well as lung cancer, across many studies. Other variants in the cluster may also 
contribute to the effect on ND by regulating gene expression. Assigning causality is difficult due 
to the high linkage disequilibrium (LD) in this region (S.-H. Lee, Ahn, Seweryn, & Sadee, 2018). 
In addition to the key genes involved in nicotine metabolism, genes involved in other 
pathways may also play a role in ND. Genome-wide association studies (GWAS) can assess 
millions of single-nucleotide variants (SNVs) for correlations with different smoking phenotypes, 
such as CPD, ND, and smoking cessation. Unfortunately, the majority of GWAS have been 
conducted in individuals of European descent. Given the distinct differences in LD between ethnic 
groups, applying results from these studies to the Samoan population is difficult. Once again, this 
highlights the importance of focusing on more diverse groups in these large-scale studies (Yoon 
et al., 2012). 
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A few GWAS have been conducted in East Asian populations, which are more similar to 
Samoans due to their evolutionary past. Yoon et al. conducted the first GWAS on smoking 
behaviors in an Asian population. They assessed 352,228 SNVs in a cohort of 8,842 Korean 
individuals for associations between these genetic variants and the smoking-related phenotypes, 
ND and smoking initiation (SI). Ordinal categories of CPD were used as a measure of ND, while 
SI was defined as a binary trait comparing individuals who never smoked to those who have had 
regular smoking experiences in their lifetime. Because an independent sample of Asian smokers 
was not available, they replicated their findings in European-Americans and African-Americans. 
The researchers discovered two SNVs that were significantly associated with SI: rs7747583 (pmeta 
= 6.40×10−6) and rs2349433 (pmeta = 5.57×10−6). Both are located on chromosome 6 in the RGS17 
gene, which regulates G-protein signaling, and are in complete LD. They also identified two SNVs 
that were associated with ND. One of these, rs4424567 (pmeta = 2.30×10−6), was on chromosome 
10 in the intronic region of the FRMD4A gene, which encodes a scaffolding protein. The other 
SNV, rs848353 (pmeta = 9.16×10−8), was on chromosome 7 at the q31.1 locus. The team 
hypothesized a few biologically plausible interpretations that support these results, but further 
research into the function of these genes is needed (Yoon et al., 2012). 
Matoba et al. conducted a GWAS for smoking-related traits (SI, smoking cessation, age of 
smoking initiation, and CPD) in a sample of 165,436 Japanese individuals and tested 6,108,828 
imputed SNVs. They identified three new loci associated with CPD (EPHX2–
CLU, RET, and CUX2–ALDH2) and three loci associated with SI (DLC1, CXCL12–TMEM72-
AS1, and GALR1–SALL3). In particular, the lead SNV (highest association significance) of DLC1, 
rs117036946, is close to rs289519 which was found to be associated with ND in a previous GWAS 
in African Americans. The association of rs117036946 with SI remained significant even after 
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accounting for LD between the two SNVs (p = 4.3×10−8), suggesting that they are two independent 
signals. Furthermore, several of these loci were identified in a sex-stratified GWAS, indicating 
that the genetics of SI significantly varies not only by ethnicity, but also by sex (Matoba et al., 
2019). 
The difficulty with both of the above GWA studies is the lack of proper replication samples 
to confirm their findings. Unfortunately, most studies on smoking initiation and ND have only 
been done in Caucasian populations, although tobacco use is a significant health concern plaguing 
Asia and the Pacific Islands. This situation makes it even more imperative to conduct research in 
other populations to gain insights regarding smoking addiction and its underlying risk factors. 
1.4 Specific Aims 
The goal of this study is to determine if gene variants associated with smoking in other 
populations have similar effects in Samoans. Specifically, I will: 
1. Analyze demographic data and distribution of smoking behaviors among the Samoan 
population. 
2. Identify genes and SNVs reported to be associated with SI and ND in the literature. 
3. Compare the frequencies of these risk alleles in Samoans to the AFs in other ethnic groups. 




2.1 Samples & Genotyping 
The SNV and covariate data on Samoans came from the Soifua Manuia (Good Health) 
study which focused particularly on the issue of obesity and other related cardiometabolic 
disorders in Samoa. A total of 3,476 participants across 33 villages in Samoa were surveyed using 
a questionnaire about their health, family history, and various health behaviors. 
All participants in this study gave written informed consent in Samoan language consent 
forms. The research in Samoa was reviewed and approved by the institutional review boards of 
Miriam Hospital, Providence, RI; Brown University; University of Cincinnati; and University of 
Pittsburgh. Research in Samoa was also reviewed and approved by the Health Research Committee 
of the Samoan Ministry of Health. 
Of the participants, 3,072 individuals were genotyped for 659,492 markers using an 
Affymetrix 6.0 chip (Minster et al., 2016). Only individuals whose maternal and paternal 
grandparents were of Samoan ancestry were eligible for the study. Many variants in the genes 
involved in nicotine metabolism (CYP2A6, CYP2B6, CHRNA5, etc.) were not included on the chip, 
and I did not have access to imputed data which was a major limitation in my analysis. 
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2.2 Smoking-Related Phenotypes 
2.2.1  Current Smoking Status 
Current smoking status (CS) was defined as a binary trait, comparing individuals who 
currently smoke to those who do not. A better assessment of smoking status would have been to 
compare individuals who were smokers at any point in their lifetime (current or former) to those 
who have never smoked. However, there were many discrepancies in participants reporting 
smoking cessation, so I was unable to accurately determine which individuals were former 
smokers and include them in my analyses. 
2.2.2  Cigarettes Per Day 
The number of cigarettes smoked per day (CPD) was defined as a continuous trait and used 
as an indicator of nicotine dependence (ND). I was unable to develop other measures of ND that 
are commonly used in the literature, such as the Fagerström Test for Nicotine Dependence 
(FTND), because this information was not asked in the questionnaire. The primary form of tobacco 
use in Samoa was manufactured cigarettes, but the survey also included questions about alternate 
forms of tobacco use, and individuals reported using hand-rolled cigarettes, pipes, and cigars. 
Because many participants used alternate forms of tobacco, I converted these products to the 
equivalent number of cigarettes based on nicotine content (Table 1). Nicotine levels in cigarettes 
vary by manufacturer, so I set the mean nicotine content (1.45 mg) as the standard for one cigarette. 
Thus, for example, one pipe has approximately the same amount of nicotine as four cigarettes. To 
correct for the many outliers (likely a result of inaccurate reporting), I plotted the log10 of the total 
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CPD and excluded any values greater than three standard deviations below/above the mean. I used 
the log-transformed data in subsequent regression analyses to adjust for the highly skewed 
distribution of CPD (Figure 3). 
 
Table 1 Nicotine content in tobacco products 
Tobacco product Nicotine content (mg) Equivalent # of cigarettes 
Cigarette 1.1–1.8 1 
Pipe 5.2 4 
Cigar 13.3 9 
(Essenmacher, 2012) 
2.3 Candidate Genes & SNVs 
After conducting an extensive literature review (Section 1.3.2) and comparing the results 
to genomic databases, such as dbSNP and the GWAS Catalog, I compiled a list of genes and SNVs 
reported to be significantly associated with smoking status and CPD. Most genomic databases do 
not contain information on Samoans, or Polynesians in general, and very few genetic studies have 
been conducted in these populations. Therefore, I used studies and data on East Asian (EAS) 
populations as the standard for comparison. Unfortunately, many of the variants previously 
associated with risk of smoking were not included on the chip used for the Soifua Manuia study. 
Moreover, several risk variants were too rare in Samoa (MAF > 0.01) to obtain meaningful results 
and were excluded from further analysis. Table 2 below lists the SNVs I used for association 
testing, along with their location in the genome, alleles, and minor allele frequency (MAF) in the 
Samoan population. 
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Table 2 Candidate SNVs associated with smoking behaviors 






2 LOC105374754 ncRNA (Intron) rs6718569 T C 0.1799 
(Matoba et al., 
2019) 
6 RGS17 Intron rs2349433 G A 0.4227 
(Yoon et al., 
2012) 
7 – Intergenic rs848353* A G 0.1267 
(Yoon et al., 
2012) 
7 – Intergenic rs1404697* G C 0.1210 
(Yoon et al., 
2012) 
10 FRMD4A Intron rs4424567 A G 0.4841 
(Yoon et al., 
2012) 
10 HECTD2-AS1 (–) ncRNA (Intron) rs1329650 T G 0.2417 
(Furberg et al., 
2010) 
11 BDNF-AS (+) 
ncRNA (Intron) rs1013442 A T 0.4755 
(Furberg et al., 
2010) 
ncRNA (Intron) rs4923460* T G 0.4430 
ncRNA (Intron) rs879048* C A 0.4189 
11 BDNF (–) Missense rs6265 T C 0.4314 
(Furberg et al., 
2010) 
15 HYKK 
Intron rs9788682 G A 0.1473 
(Furberg et al., 
2010) 
Intron rs7163730 A G 0.2314 
(Li et al., 
2010) 
(Furberg et al., 
2010) 
15 CHRNA3 Intron rs6495308 C T 0.4904 
(Liu et al., 
2010) 
(Li et al., 
2010) 
15 CHRNA5 Intron rs16969948 A G 0.1644 
(Li et al., 
2010) 
15 CHRNB4 Upstream Variant rs7166158 A T 0.2263 
(Li et al., 
2010) 
15 LOC112268142 ncRNA (Intron) rs8043123 T C 0.4151 
(Li et al., 
2010) 
15 – ncRNA (Intron) rs11072793 G A 0.3873 
(Li et al., 
2010) 
17 CAMKK1 Intron rs758642 G A 0.1478 
(Caporaso et 
al., 2009) 
19 EGLN2 Intron rs3733829 G A 0.4352 
(Furberg et al., 
2010) 
19 CYP2B6 Missense rs3745274 G T 0.3852 
(Zanger et al., 
2007) 
 
A2 refers to the minor allele in Samoans. MAF is the frequency of this allele in the Samoan population. 
*SNVs in high LD: rs848353 and rs1404697 (r2 = 1); rs4923460 and rs879048 (r2 = 0.83) 
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2.4 Statistical Testing 
2.4.1  Population Characteristics 
The difference in mean age of male and female participants was compared using a two-
sample t test with pooled variance. Differing trends in smoking behaviors were analyzed with a 
two-sample Z test (CS) or two-sample t test with unequal variances (CPD). The threshold p-value 
for all the tests was 0.05. 
2.4.2  Principal Component Analysis 
Principal component analysis (PCA) was used to compare allele frequencies (AFs) of the 
20 SNVs of interest (Table 2) in Samoans to those in other populations. I obtained the AFs of the 
candidate SNVs from the dbSNP database and used the populations defined by the 1000 Genomes 
Project. I performed the PCA and plotted the results using the prcomp() function in the stats R 
package and the autoplot() function in ggplot2. 
2.4.3  Association Testing 
In order to determine if the SNVs found in the literature were associated with the smoking-
related phenotypes in the Samoan population, I used the glm() function in the stats R package to 
perform logistic and linear regression analyses, adjusting for sex as a covariate due to the 
significant difference in smoking patterns between males and females. A logistic regression model 
was fit for the binary phenotype CS, and a linear regression model was fit for CPD. For both 
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phenotypes, I coded the alleles additively (number of copies of the minor allele) to determine if 
there was a dosage effect, as well as by genotype. The major allele or homozygous major allele 
genotype, respectively, was designated as the reference. I calculated odds ratios (OR) and 95% 
confidence intervals using the confint() function in R. 
A threshold p-value of 0.003 was established after correcting for multiple testing and 
accounting for LD. I used the NIH’s SNPclip tool to determine the number of SNVs with R2 less 
than 0.8, which I considered to be independent SNVs; only AFs from East Asian populations were 
included because they share the closest genetic similarity to Samoans. Then, I divided the nominal 
significance level of 0.05 by the number of independent SNVs (18) to obtain the adjusted 




More females (58.7%) than males (41.3%) participated in this study (Table 3). The ages of 
the study participants ranged from 22 to 70, with a mean age of ~45, and the difference in mean 
age between males and females was not significant. Because the original target age range of the 
study was 25 to 65, there were very few participants between the ages of 20 to 25, but the number 
of individuals in the other age groups was equally distributed (Figure 1). 
 
Table 3 Demographic variables 
Characteristic 
Total 
(n = 3476) 
Males 
(n  = 1436)(41.3%) 
Females 
(n = 2040)(58.7%) 
p-value 
(between genders) 
Age (mean ± SD) 44.8 ± 11.2 45.1 ± 11.4 44.6 ± 11.1 0.2 
Current smoker 1181 (34.0%) 735 (51.2%) 446 (21.9%) < 2.2×10-16 




Figure 1 Age distribution of study participants 
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3.2 Smoking Trends & Distribution 
The distribution of smoking status was analyzed by sex to see if there were any differences 
between the groups. Table 3 shows that 34% of the study sample were current smokers. However, 
the smoking frequency in males was significantly higher than in females (51% versus 22% 
respectively;   p < 2.2×10-16); more than half of all male participants in the study were smokers. 
The majority of participants started smoking in their late teens and early twenties (Figure 
2). As described in the Methods, all tobacco products were converted into the equivalent number 
of cigarettes based on nicotine content. The mean CPD among the Samoan population was 11.3. 
Yet, just as smoking frequency differed by gender, mean CPD also differed significantly by gender 
(Table 3). The mean CPD in males was 12.7, whereas in females it was 8.9 (p = 2.0×10-12). 
Furthermore, as can be seen by the skewed distribution in Figure 3, 94.8% of participants smoked 
less than or equal to the nicotine content in a pack of cigarettes per day (~20 cigarettes), and 68.4% 
smoked less than or equal to half a pack per day. However, 2% of individuals smoked 
approximately two packs a day, and a few individuals smoked nearly 4–5 packs per day. 
 
 
Figure 2 Age of smoking initiation 
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Figure 3 Cigarettes smoked per day 
3.3 Allele Frequencies 
Table 4 presents SNV allele frequencies (AFs) for Samoans and other “superpopulation” 
groups, as defined by the 1000 Genomes Project (Appendix Table 1). The frequencies of several 
alleles differed between Samoans and other populations. For example, the AF of rs3733829 [A] is 
0.4352 in Samoans but ranges from 0.5060 to 0.9758 in the other populations; thus, the minor and 
major alleles are switched for this SNV. 
To assess the overall relationships among the populations, I conducted principal 
component analysis (PCA) using the AFs of the 20 SNVs from each population (Table 4) and 
plotted the first and second principal components. These two components accounted for 45.71% 
and 28.61% of the variance, respectively, among AFs across the populations (Figure 4). The PCA 
plot displays the similarity between the Samoan and East Asian AFs by clustering them together. 
The South Asian, American (admixed Latino), and European populations loosely formed another 
cluster, whereas the African (sub-Saharan) populations were least similar to the other groups. 
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Table 4 Allele frequencies by population 
Chromosome SNV Samoan East Asian American South Asian European African 
2 rs6718569 [C] 0.1799 0.1101 0.2450 0.0600 0.0666 0.2617 
6 rs2349433 [A] 0.4227 0.3671 0.6240 0.4790 0.7048 0.4561 
7 rs848353 [G] 0.1267 0.1429 0.0940 0.0710 0.0696 0.3593 
7 rs1404697 [C] 0.1210 0.1429 0.0620 0.0690 0.0596 0.0378 
10 rs4424567 [G] 0.4841 0.5536 0.4350 0.3940 0.2763 0.1452 
10 rs1329650 [G] 0.2417 0.2619 0.6010 0.3850 0.7187 0.9380 
11 rs1013442 [T] 0.4755 0.1498 0.2870 0.2720 0.2485 0.0280 
11 rs4923460 [G] 0.4430 0.5556 0.8210 0.7290 0.7803 0.8381 
11 rs879048 [A] 0.4189 0.5139 0.8070 0.7380 0.7813 0.6014 
11 rs6265 [C] 0.4314 0.5119 0.8470 0.7980 0.8032 0.9894 
15 rs9788682 [A] 0.1473 0.2887 0.4710 0.3920 0.2207 0.1747 
15 rs7163730 [G] 0.2314 0.4256 0.5240 0.4030 0.2356 0.2458 
15 rs6495308 [T] 0.4904 0.2669 0.4500 0.5300 0.7594 0.6762 
15 rs16969948 [G] 0.1644 0.0585 0.0140 0.0020 0.0020 0.1437 
15 rs7166158 [T] 0.2263 0.2500 0.1250 0.0700 0.0775 0.1498 
15 rs8043123 [C] 0.4151 0.5308 0.5040 0.5340 0.7624 0.8222 
15 rs11072793 [A] 0.3873 0.4573 0.6240 0.5260 0.7465 0.2005 
17 rs758642 [A] 0.1478 0.1349 0.3570 0.2920 0.3459 0.3623 
19 rs3733829 [A] 0.4352 0.6419 0.5060 0.5860 0.6372 0.9758 




Figure 4 PCA plot of population allele frequencies 
3.4 Association Analyses 
The effect of the SNVs on CS and CPD in Samoans was analyzed using logistic and linear 
regression models with sex as a covariate. I coded the alleles additively (number of copies of the 
minor allele) to determine if there was a dosage effect, and I also analyzed them by genotype. 
Tables 5 and 6 contain the SNVs with suggestive (p ≤ 0.01) and significant results (p ≤ 0.003) 
from these tests. The complete tables are provided in the Appendix (Appendix Tables 1 and 2). 
Homozygotes for the minor allele [G] for SNV rs848353 had significantly higher odds of 
being current smokers than heterozygotes or homozygotes for the major allele [A] (OR = 2.635 
[2.433–35.631]; p = 0.001). In other words, two copies of the minor allele [G] more than doubled 
the odds of being a smoker. Figure 5 shows that ~50% of individuals with the genotype GG were 
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current smokers, which was higher than the proportion of smokers with the other genotypes. In 
contrast, homozygotes for the minor allele [T] for SNV rs3745274 were less likely to be smokers, 
although this effect did not meet the threshold for significance (OR = 0.710 [0.253–0.809]; p = 
0.008). 
For CPD, homozygotes for the minor allele [G] for SNV rs1329650 smoked significantly 
more cigarettes per day than heterozygotes or homozygotes for the more frequent allele [T] ( = 
0.146  0.044; p = 0.001). This meant that having two copies of the risk allele [G] corresponded 
to an increase in smoking quantity of 0.146 CPD compared to baseline. Figure 6 shows that the 
distribution of the log10 of CPD for the genotype GG only contained values of CPD at the higher 
end of the range and was clearly different from the distributions for the other genotypes. 
 





OR [95% CI] p-value   SE p-value 
rs3745274 G T 0.696 [0.532–0.911] 0.008   
rs1329650 T G   0.049 ± 0.017 0.004 
 
 
Table 6 SNVs associated with smoking phenotypes (by genotype) 
SNV Genotype 
CS CPD 
OR [95% CI] p-value   SE p-value 
rs848353 
AA Reference (1.000)       
AG 0.960 [0.586–1.407] 0.673   
GG 2.635 [2.433–35.631] *0.001   
rs3745274 
GG Reference (1.000)       
GT 0.887 [0.514–1.119] 0.163   
TT 0.710 [0.253–0.809] 0.008   
rs1329650 
TT     Reference (0.000)   
TG   0.025 ± 0.022 0.266 
GG   0.146 ± 0.044 *0.001 
 
*Below significance threshold (p ≤ 0.003) 
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Figure 5 Proportion of smokers by genotype for rs848353 
 
 
Figure 6 Distribution of CPD by genotype for rs1329650 
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4.0 Discussion 
Smoking tobacco is a risk factor for many chronic conditions, including lung cancer, heart 
disease, and respiratory diseases, which are among the leading causes of death around the world.  
Although tobacco use has decreased in the past decades, Southeast Asia and the Pacific Islands 
continue to have some of the highest rates of smoking in the world, ranging from 30–50% of the 
population (Adia et al., 2019). In Samoa, in particular, 39.5% of men and 16.8% of women were 
smokers (Linhart et al., 2017). However, a majority of Samoans reported a desire to quit smoking, 
but nicotine dependence makes smoking cessation difficult. In my analysis, I used demographic 
and genotype data from the Soifua Manuia (Good Health) study to assess whether risk alleles for 
smoking susceptibility in other populations were associated with smoking behaviors in Samoans. 
The percentages of current smokers among participants in the Soifua Manuia study (51.2% 
of males; 21.9% of females) were higher than those in a previous study, particularly the percentage 
of male smokers. Linhart and colleagues reported that 39.5% of males and 16.8% of females in 
Samoa were smokers. The difference between the two studies may be attributed to sample size; 
Linhart et al. used population-based surveys from a total of 9,223 individuals, whereas only 3,476 
individuals participated in the Sofiua Manuia study. 
However, the distribution of age of smoking initiation was similar to trends seen in other 
populations. Most individuals start smoking in their late teens and early twenties, most likely in a 
social setting in which their peers are also smoking (Tanielu et al., 2018). The same result was 
observed in this study sample; the majority of participants (71.7%) began smoking between the 
ages of 15 to 25. 
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Comparing patterns pertaining to CPD with studies in other populations is difficult because 
each study measured the variable differently. Many studies transformed the continuous variable 
into ordinal categories, and most did not indicate that they included alternate forms of tobacco use. 
Adia et al. reported that the mean CPD among Samoan men and women was 10.9 and 8.7, 
respectively, whereas the mean CPD for the Soifua Manuia study participants was 12.7 for males 
and 8.9 for females. The higher mean may be due to the integration of alternate forms of tobacco 
use (hand-rolled cigarettes, pipes, and cigars) into my analyses. Unfortunately, few studies have 
quantitatively analyzed smoking behaviors among Samoans; thus, it is difficult to make any overall 
conclusions regarding smoking rates and CPD in Samoa until additional research is conducted. 
The logistic regression analyses of current smoking status (CS) and general linear model 
methods for CPD identified SNVs that have a significant effect on both traits. I found that 
homozygotes for the minor allele for SNV rs848353 [G] were 2.6 times more likely to be smokers 
than homozygotes for the major allele [A] (OR = 2.635 [2.433–35.631]; p = 0.001). The large 
confidence interval for the odds ratio is due to the small sample size of individuals that were 
homozygous for the minor allele (n = 51). Yoon et al. also reported an association between SNV 
rs848353 and increased smoking behaviors. They found that the minor allele was significantly 
associated with higher CPD (OR = 1.37; p = 5.43×10-6), which they coded as an ordinal phenotype 
comprising five levels. They conducted the GWAS in a Korean population and replicated their 
findings in European American and African American populations. Although this SNV affected 
different smoking phenotypes in Samoans, Koreans, European Americans, and African 
Americans, the minor allele was associated with an increase in the risk of smoking susceptibility 
overall. SNV rs848353 is located on the long arm of chromosome 7q31.1 and is an intergenic locus 
that has been linked to various disorders related to ulcerative colitis, cognitive performance, and 
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serum metabolites. However, its role in the etiology of these complex phenotypes, as well as 
smoking-related traits, is still unknown (Yoon et al., 2012). 
The results also suggested a correlation between SNV rs3745274 in the CYP2B6 gene and 
CS, although the association did not meet the threshold for significance; a larger sample size of 
individuals is needed to confirm this finding. The minor allele [T] had a protective effect and 
homozygotes were less likely to be smokers (OR = 0.710 [0.253–0.809]; p = 0.008). The gene’s 
role in nicotine metabolism makes it a potential target for pharmacotherapies. Bupropion, a drug 
widely used to help with smoking cessation, is metabolized into hydroxybupropion by the 
CYP2B6 enzyme (Zanger et al., 2007). A previous clinical study reported that among individuals 
who were heterozygous or homozygous for SNV rs3745274 [T], bupropion produced significantly 
higher rates of smoking cessation than the placebo (32.5% versus 14.3% respectively; p = 0.01) 
(A. M. Lee et al., 2007). These findings have useful implications for selecting the best candidates 
for bupropion treatment. Moreover, the variant allele [T] has the highest frequency in Papua New 
Guineans (62%), so bupropion therapy could be particularly beneficial in Polynesians, who have 
20-30% Papuan ancestry (Zanger et al., 2007). 
I detected a significant association between SNV rs1329650 and CPD. Homozygotes for 
the minor allele [G] had an increase of 0.146 CPD compared to homozygotes for the major allele 
[T] ( = 0.146  0.044; p = 0.001). The variant seemed to have a dominance effect with respect to 
CPD; the major allele was dominant, the minor allele was recessive, and heterozygotes [TG] had 
similar CPD counts to dominant homozygotes [TT] ( = 0.025 ± 0.022; p = 0.266). Furberg et al. 
conducted meta-analyses of smoking behaviors across three different consortia (Tobacco and 
Genetics Consortium, European Network of Genetic and Genomic Epidemiology, and Oxford-
GlaxoSmithKline) and reported similar results. They coded CPD as a continuous variable and 
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found that “each additional copy of the risk allele [G] corresponded to an increase in smoking 
quantity of ~0.5 CPD” ( = 0.367  0.059; p = 5.7×10-10) (Furberg et al., 2010). SNV rs1329650 
is located on chromosome 10q23.32 in a noncoding RNA (ncRNA), the antisense strand of the 
HECTD2 gene. This region has not previously been implicated in nicotine dependence or other 
substance use disorders, and little is known about its function, as is the case with many noncoding 
regions. 
Although some SNVs associated with smoking behaviors in other populations had similar 
effects in Samoans, additional risk loci specific to Samoans may exist. Samoans are a unique 
population, distinguished by their evolutionary history and relatively isolated geographic location 
in the middle of the Pacific Ocean. Their genetic history is reflected in their allele frequencies 
(AFs) for various SNVs which differed significantly from AFs in other populations. Although I 
included only 20 SNVs in my analysis, and these variants were not definitive markers of ancestry, 
the clustering of populations by AFs was clearly seen in the PCA plot (Figure 4). Overall, the 
frequencies of these 20 loci in Samoans were most similar to those in East Asians which is likely 
attributable to their ancestral and evolutionary history. I would have liked to compare the Samoan 
AFs to those in other Polynesian populations (e.g., Māori, Tongan, Hawaiian, etc.) to assess how 
all the Polynesians clustered in relation to East Asians. However, none of the genomic databases 
contained information on Polynesians because they have not been included in any major 
sequencing projects, and few GWAS studies have been conducted in these populations, 
highlighting the lack of diversity in genetics research. 
The results of this study emphasized the extent to which smoking is a major public health 
concern in Samoa. Despite significant improvements in smoking rates over the past decades, the 
problem persists. More than half of all male participants in this study were smokers, indicating 
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that further intervention is necessary. By researching the social and genetic factors influencing 
tobacco use and cessation, we can develop more effective strategies for mitigating its prevalence, 
eventually leading to a decrease in chronic disease morbidity and mortality and overall improving 
public health in Samoa. 
4.1 Limitations 
The key limitations in this study were related to the variants on the genotyping chip, sample 
size, inaccurate reporting, and lack of comparable research. As discussed in the Background and 
Methods, variants in many genes known to be involved in nicotine metabolism and dependence 
were not assayed on the genotyping chip used for the Soifua Manuia study. Thus, I was not able 
to include these risk loci in my analyses and measure their effect on smoking behaviors in 
Samoans. Sample size was another limitation; although the overall sample size used for the 
association testing was adequate (n = 3072), few individuals were homozygous for the minor 
allele. This result is to be expected because, by definition, the minor allele is present at a lower 
frequency in the population. The issue of sample size was exacerbated because I had to exclude 
some participants from the analyses due to inaccurate reporting of CPD. Another way to adjust for 
the outliers and skewed distribution of CPD would have been to transform the continuous variable 
into ordinal categories (10 CPD, 11–20 CPD, etc.); this approach will be used in any future 
studies. As mentioned in the Methods, I could not include former smokers in my assessment of 
smoking status due to missing data on smoking cessation. The lack of comparable research 
presented another problem; few genetic studies have been conducted in Samoans, or Polynesians 
in general, and none of these studies analyzed smoking behaviors. Furthermore, previous studies 
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of smoking in other populations defined different smoking phenotypes, using measures I could not 
assess, such as smoking cessation and the Fagerström Test for Nicotine Dependence (FTND). 
These studies also did not include alternate forms of tobacco use. In converting these tobacco 
products into cigarette equivalents, I made the assumption that nicotine was absorbed in the same 
way. However, nicotine absorption is much higher when smoking cigarettes because the smoke is 
inhaled into the lungs. Overall, these limitations highlighted the need for additional research to 
replicate my findings and confirm whether the identified loci are truly associated with increased 
risk of smoking in Samoans. 
4.2 Future Research 
A GWAS of smoking behaviors in Samoans should be conducted to follow-up the results 
from this study; imputed genotypes should be used so that all of the known genetic variants 
associated with nicotine metabolism and dependence can be analyzed. Identification of additional 
risk loci may enable development of targeted interventions for smoking cessation. After further 
investigation into current cessation therapies used in Samoa, we can determine whether commonly 
used drugs are effective in this population and develop new treatments using a pharmacogenetics-
based approach. 
This study highlighted many gaps in our current understanding of noncoding regions of the 
genome and their implication in complex phenotypes, such as nicotine dependence. Both of the 
SNVs found to be significantly associated with smoking behaviors in this study were located in 
noncoding regions, and extensive research is needed in order to gain a thorough understanding of 
their function. This study also emphasized the lack of research being conducted in diverse 
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populations. Unfortunately, the scientific community is neglecting important parts of human 
evolutionary history; we need to include individuals from all ethnic groups if we want to decipher 
the puzzle that is the human genome and develop interventions to improve population health. 
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Appendix  
Appendix Table 1 Populations in the 1000 Genomes Project 
Superpopulation Population description 
East Asian 
Han Chinese in Beijing, China 
Japanese in Tokyo, Japan 
Southern Han Chinese 
Chinese Dai in Xishuangbanna, China 
Kinh in Ho Chi Minh City, Vietnam 
Admixed American 
Mexican Ancestry in Los Angeles, California 
Puerto Ricans in Puerto Rico 
Colombians in Medellin, Colombia 
Peruvians in Lima, Peru 
South Asian 
Gujarati Indians in Houston, Texas 
Punjabis in Lahore, Pakistan 
Bengalis in Bangladesh 
Sri Lankan Tamils in UK 
Indian Telugus in UK 
European 
Northern and Western European Ancestry in Utah (CEPH) 
Tuscans in Italy 
Finnish in Finland 
British in England and Scotland 
Iberian Population in Spain 
African 
Yoruba in Ibadan, Nigeria 
Luhya in Webuye, Kenya 
Gambians in Western Divisions in Gambia 
Mende in Sierra Leone 
Esan in Nigeria 
African Ancestry in SW USA 
African Caribbeans in Barbados 
("Which populations are part of your study?,") 
 





OR [95% CI] p-value   SE p-value 
rs6718569 T C 0.945 [0.675–1.317] 0.739 0.005 ± 0.020 0.795 
rs2349433 G A 0.911 [0.702–1.180] 0.480 -0.010 ± 0.015 0.505 
rs848353 A G 1.270 [0.867–1.854] 0.218 -0.006 ± 0.021 0.786 
rs1404697 G C 1.111 [0.741–1.659] 0.609 -0.008 ± 0.023 0.732 
rs4424567 A G 1.026 [0.867–1.854] 0.840 0.014 ± 0.015 0.328 
rs1329650 T G 0.936 [0.696–1.258] 0.663 0.049 ± 0.017 *0.004 
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rs1013442 A T 0.880 [0.680–1.137] 0.327 -0.001 ± 0.015 0.927 
rs4923460 T G 1.051 [0.814–1.358] 0.702 0.006 ± 0.015 0.717 
rs879048 C A 1.061 [0.821–1.371] 0.649 0.002 ± 0.015 0.889 
rs6265 T C 1.053 [0.814–1.361] 0.695 0.005 ± 0.015 0.752 
rs9788682 G A 0.660 [0.449–0.965] 0.033 0.025 ± 0.023 0.277 
rs7163730 A G 0.832 [0.613–1.127] 0.237 0.025 ± 0.018 0.158 
rs6495308 C T 1.215 [0.944–1.565] 0.130 -0.029 ± 0.015 0.052 
rs16969948 A G 0.899 [0.638–1.261] 0.537 -0.008 ± 0.020 0.687 
rs7166158 A T 1.092 [0.806–1.477] 0.569 0.008 ± 0.017 0.658 
rs8043123 T C 0.993 [0.766–1.286] 0.956 -0.030 ± 0.015 0.048 
rs11072793 G A 1.018 [0.785–1.319] 0.893 -0.034 ± 0.015 0.022 
rs758642 G A 0.972 [0.676–1.393] 0.877 -0.012 ± 0.021 0.562 
rs3733829 G A 1.072 [0.825–1.392] 0.604 0.014 ± 0.015 0.371 
rs3745274 G T 0.696 [0.532–0.911] *0.008 0.020 ± 0.016 0.211 
 
*Suggestive association (p ≤ 0.01) 
 
Appendix Table 3 Results of association testing (by genotype) 
SNV Genotype 
CS CPD 
OR [95% CI] p-value   SE p-value 
rs6718569 
TT Reference (1.000)  Reference (0.000)  
TC 1.013 [0.692–1.529] 0.886 0.013 ± 0.023 0.561 
CC 0.824 [0.211–1.833] 0.416 -0.028 ± 0.067 0.679 
rs2349433 
GG       
GA 0.994 [0.660–1.476] 0.946 -0.016 ± 0.023 0.483 
AA 0.909 [0.469–1.369] 0.422 -0.018 ± 0.032 0.578 
rs848353 
AA        
AG 0.960 [0.586–1.407] 0.673 -0.009 ± 0.026 0.725 
GG 2.635 [2.433–35.631] **0.001 0.000 ± 0.067 0.997 
rs1404697 
GG        
GC 0.969 [0.599–1.437] 0.744 -0.058 ± 0.030 0.333 
CC 2.301 [1.135–38.965] 0.032 0.109 ± 0.094 0.250 
rs4424567 
AA        
AG 1.030 [0.698–1.649] 0.753 -0.014 ± 0.025 0.575 
GG 1.021 [0.636–1.734] 0.849 0.031 ± 0.029 0.290 
rs1329650 
TT        
TG 0.949 [0.604–1.297] 0.534 0.025 ± 0.022 0.266 
GG 0.992 [0.451–2.098] 0.963 0.146 ± 0.044 **0.001 
rs1013442 
AA        
AT 1.082 [0.783–1.839] 0.406 0.020 ± 0.025 0.414 
TT 0.879 [0.441–1.251] 0.265 -0.006 ± 0.031 0.835 
rs4923460 TT         
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TG 1.162 [0.934–2.140] 0.103 0.029 ± 0.024 0.238 
GG 1.012 [0.608–1.732] 0.919 0.005 ± 0.031 0.864 
rs879048 
CC        
CA 1.078 [0.794–1.782] 0.402 0.020 ± 0.024 0.401 
AA 1.034 [0.637–1.827] 0.772 -0.002 ± 0.031 0.947 
rs6265 
TT         
TC 1.190 [0.993–2.251] 0.054 0.028 ± 0.024 0.237 
CC 0.997 [0.583–1.683] 0.977 0.002 ± 0.031 0.949 
rs9788682 
GG         
GA 0.848 [0.446–1.042] 0.078 0.027 ± 0.025 0.284 
AA 0.624 [0.064–1.524] 0.176 0.033 ± 0.098 0.740 
rs7163730 
AA         
AG 0.904 [0.540–1.163] 0.237 0.016 ± 0.023 0.477 
GG 0.896 [0.336–1.750] 0.547 0.073 ± 0.049 0.136 
rs6495308 
CC         
CT 1.200 [0.981–2.363] 0.062 -0.040 ± 0.026 0.125 
TT 1.183 [0.886–2.452] 0.135 -0.058 ± 0.030 0.051 
rs16969948 
AA         
AG 0.927 [0.555–1.264] 0.402 -0.017 ± 0.024 0.472 
GG 1.011 [0.353–2.862] 0.964 0.015 ± 0.061 0.801 
rs7166158 
AA         
AT 0.973 [0.639–1.378] 0.748 0.006 ± 0.023 0.784 
TT 1.255 [0.747–3.757] 0.203 0.018 ± 0.045 0.684 
rs8043123 
TT         
TC 1.014 [0.692–1.546] 0.872 -0.022 ± 0.023 0.355 
CC 0.986 [0.566–1.652] 0.909 -0.064 ± 0.031 0.042 
rs11072793 
GG         
GA 0.937 [0.580–1.275] 0.452 -0.024 ± 0.023 0.288 
AA 1.058 [0.661–1.950] 0.640 -0.074 ± 0.031 0.019 
rs758642 
GG         
GA 0.963 [0.602–1.391] 0.683 -0.015 ± 0.024 0.553 
AA 1.103 [0.351–4.243] 0.721 -0.014 ± 0.075 0.855 
rs3733829 
GG         
GA 0.952 [0.591–1.349] 0.589 0.038 ± 0.024 0.118 
AA 1.088 [0.715–2.059] 0.471 0.021 ± 0.031 0.502 
rs3745274 
GG         
GT 0.887 [0.514–1.119] 0.163 0.023 ± 0.023 0.313 
TT 0.710 [0.253–0.809] *0.008 0.037 ± 0.034 0.281 
 
*Suggestive association (p ≤ 0.01) 
**Below significance threshold (p ≤ 0.003) 
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